Nanobiotix(DE:5NR)
€28.36+0.10 (+0.35%)
DE:5NR
Nanobiotix Revenue
€28.36
At close:+0.10 (+0.35%)
Nanobiotix (5NR) Revenue
3 Followers
Nanobiotix Revenue
Nanobiotix had a revenue of 5.55M in the quarter ending Jun 30, 2026, with 84.73%. This bring the company's revenue in the last twelve months to 8.56M, Decreased 71.14%. In the fiscal year ending Dec 31, 2025, Nanobiotix had annual revenue of 29.64M with 355.34% growth.
- Revenue (ttm)
- 8.56M
- Revenue Growth
- ―
- P/S Ratio
- 49.88
- Revenue/Employee
- EUR 302,480
- Employees
- 98
- Market Cap
- EUR 1.48B
Revenue Chart
Nanobiotix Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 29.64M | 41.25M | -355.34% |
| Dec 31, 2024 | -11.61M | -41.67M | -138.62% |
| Dec 31, 2023 | 30.06M | 25.28M | 529.36% |
| Mar 31, 2023 | 4.78M | 4.77M | 47660.00% |
| Dec 31, 2021 | 10.00K | -40.00K | -80.00% |
| Dec 31, 2020 | 50.00K | -18.00K | -26.47% |
| Dec 31, 2019 | 68.00K | -3.41M | -98.05% |
| Dec 31, 2018 | 3.48M | -243.00K | -6.53% |
| Dec 31, 2017 | 3.72M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.